Insights On Partnering

  1. An Introduction To One Home for Sites™ 4/18/2024

    This on-demand webinar provides a thorough overview of why IQVIA Technologies is building One Home for Sites, how it works, and who should participate.

  2. Navigating Autoimmune Disease A Playbook For Cell And Gene Therapies 9/3/2025

    By integrating site readiness, patient engagement, and data-driven decision-making, the cell and gene therapies (CAGT) field is advancing toward therapies that not only control disease but transform lives.

  3. The Importance Of Cognitive And Pharmacodynamic Testing During FIH Trials 5/9/2025

    Learn how to identify which cognitive and pharmacodynamic tests are required for novel CNS-active drugs and best practices on conducting them during First-In-Human (FIH) trials.

  4. The Advantages Of Pharmacovigilance Outsourcing At The Local Level 4/14/2025

    Outsourcing pharmacovigilance tasks can free up local teams for strategic work. Learn how to build effective partnerships by aligning needs, understanding capabilities, and fostering collaboration.

  5. Clinical Trials In The Age Of Cost Caps 4/14/2025

    On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.

  6. How To Establish Effective, Scalable Drug Safety Ops Across Vendors 7/9/2024

    Numerous factors impact a drug safety program, but proper management of three key elements drives success while creating a scalable drug safety model.

  7. Optimizing EDC Strategy And Data Collection for a Rare Disease Trial 6/11/2025

    Explore how Veristat created a forward-looking roadmap for EDC and CRFs integration for a small biotech sponsor, ensuring a future-ready data ecosystem without overcomplicating current operations.

  8. A Biologic Drug's Analytical Journey 3/4/2025

    Gain valuable insights into advanced methods and analysis techniques for high-order structure, physiochemical characterization, cell-based and biochemical assays, and more.

  9. 10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves Them 7/1/2025

    Vendor selection in clinical trials is a pivotal process. Explore ten widespread inefficiencies in the current approach and how you can resolve them.

  10. Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments 1/15/2025

    Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties